Published in Life Sci on January 01, 1991
Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule. Arch Dis Child Fetal Neonatal Ed (2008) 1.53
The relationship of excess body weight and health-related quality of life: evidence from a population study in Taiwan. Int J Obes (Lond) (2006) 1.30
Adolescents in high-risk trajectory: clustering of risky behavior and the origins of socioeconomic health differentials. Prev Med (1997) 1.25
Central administration of perfluorooctanoic acid inhibits cutaneous inflammation. Inflamm Res (2005) 0.96
Extraperoxisomal targets of peroxisome proliferators: mitochondrial, microsomal, and cytosolic effects. Implications for health and disease. Crit Rev Toxicol (1998) 0.88
Biology of senescent liver peroxisomes: role in hepatocellular aging and disease. Environ Health Perspect (1999) 0.87
Return to post-test counselling by out-of-treatment injecting drug users participating in a cross-sectional survey in north Vietnam. AIDS Care (2007) 0.84
Correlation between thyroid hormone status and hepatic hyperplasia and hypertrophy caused by the peroxisome proliferator-activated receptor alpha agonist Wy-14,643. J Carcinog (2004) 0.82
Diminished energy metabolism and enhanced apoptosis in livers of B6C3F1 mice treated with the antihepatocarcinogen rotenone. Mol Cell Biochem (1999) 0.81
Carbohydrate and oxygen metabolism during hepatocellular proliferation: a study in perfused livers from mirex-treated rats. Hepatology (1991) 0.80
Regulation of perfluorooctanoic acid--induced peroxisomal enzyme activities and hepatocellular growth by adrenal hormones. Hepatology (1992) 0.79
Kinetics of aluminum in rats. III: Effect of route of administration. J Pharm Sci (1992) 0.79
Hyperinsulinemia inhibits hepatic peroxisomal beta-oxidation in rats. Horm Metab Res (1995) 0.79
Activated Kupffer cells attenuate the liver response to the peroxisome proliferator perfluorooctanoic acid. Mol Cell Biochem (1997) 0.78
Mechanism of aluminum-induced inhibition of hepatic glycolysis: inactivation of phosphofructokinase. J Pharmacol Exp Ther (1990) 0.78
Protection of liver by calcium entry blockers. Ann N Y Acad Sci (1988) 0.77
Enoximone inhibits hepatic mitochondrial long-chain acyl-CoA synthetase. Toxicol Lett (1994) 0.77
Stimulation of fatty acid oxidation by phosphodiesterase III inhibitors in rat myocytes. J Cardiovasc Pharmacol (1991) 0.77
Selective inhibition of hepatic peroxisomal fatty acid beta-oxidation by enoximone. Life Sci (1992) 0.76
Stimulation of myocyte insulin-responsive glucose transporters by the inhibition of fatty acid oxidation. Diabetes Res (1993) 0.75
Jaw problems: Update on ARONJ. Br Dent J (2015) 0.75
Ovarian adrenergic nerves directly participate in the control of luteinizing hormone-releasing hormone and beta-adrenergic receptors during puberty: a biochemical and autoradiographic study. Endocrinology (1987) 0.75
Proceedings: Effect of acetyl salicylic acid on platelet function in vivo. Thromb Diath Haemorrh (1975) 0.75
Suicide seasonality and antidepressants: a register-based study in Sweden. Acta Psychiatr Scand (2012) 0.75
Urinary bilharziasis in upper Egypt. II. A bacteriological study. East Afr Med J (1972) 0.75
The ureterocalyceal system in normal pregnancy. A study using isotope renography and intravenous pyelography. Acta Obstet Gynecol Scand (1973) 0.75
[Post-bilharzic bladder neck obstruction]. J Urol Nephrol (Paris) (1977) 0.75
Reduced induction of carbohydrate utilization by inhibition of fatty acid oxidation in myocytes from diabetic animals. Horm Metab Res (1995) 0.75
The lengthy type of post-bilharzial ureteral stricture. J Urol (1982) 0.75
The inhibition of long-chain fatty acyl-CoA synthetase by enoximone in rat heart mitochondria. J Cardiovasc Pharmacol (1992) 0.75
[Digitalis intoxication during the neonatal period: role of dehydration]. Arch Pediatr (2000) 0.75
Evaluation of hepatic metabolism of salicylic acid in perfused rat liver. J Pharm Sci (1994) 0.75
Management of bilharzial strictures of the lower ureter. Urol Int (1982) 0.75
Stimulation of polyunsaturated fatty acid oxidation in myocytes by regulating its cellular uptake. On the rate limiting step of polyunsaturated fatty acid oxidation in heart. Life Sci (1991) 0.75
Menadione causes selective toxicity to periportal regions of the liver lobule. Toxicol Lett (1987) 0.75
[Revelation of an acute lymphoblastic leukemia in the delivery room]. Arch Pediatr (2007) 0.75
[The various hysterographic pictures of the cavum uteri in uterine myomas]. Geburtshilfe Frauenheilkd (1966) 0.75
Partial flap ureteroneocystostomy for bilharzial strictures of lower ureter. Urology (1982) 0.75
Antagonism between salicylic acid and glucose in Saccharomyces cerevisiae. Toxicol Appl Pharmacol (1981) 0.75
Urinary bilharziasis in upper Egypt. I. A clinicopathological study. East Afr Med J (1972) 0.75